Molecular aspects of the imipramine 'receptor'.
D000345:Affinity Labels; D000818:Animals; D000928:Antidepressive Agents / Q000378:metabolism; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects; D001792:Blood Platelets / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002352:Carrier Proteins; D003866:Depressive Disorder / Q000378:metabolism; D006801:Humans; D007099:Imipramine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D008055:Lipids / Q000032:analysis; D009474:Neurons / Q000378:metabolism; D011487:Protein Conformation; D011506:Proteins / Q000032:analysis; D011618:Psychotic Disorders / Q000378:metabolism; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter / Q000032:analysis / Q000502:physiology*; D012701:Serotonin / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013696:Temperature; D014018:Tissue Distribution
D000345:Affinity Labels; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D002352:Carrier Proteins; D008055:Lipids; D011506:Proteins; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter; D012702:Serotonin Antagonists; D013438:Sulfhydryl Compounds; C027775:imipramine receptor; C024316:cianopramine; D012701:Serotonin; C030721:2-nitroimipramine; D012964:Sodium; D007099:Imipramine